These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Rengyolone inhibits apoptosis via etoposide-induced caspase downregulation.
    Author: Kim JH, Lee CH.
    Journal: J Microbiol Biotechnol; 2009 Mar; 19(3):286-90. PubMed ID: 19349754.
    Abstract:
    In the course of screening for substances inhibiting apoptosis of U937 human leukemia cells induced by etoposide (10 microg/ml), Forsythiae fructus, which showed a high level of inhibition, was selected. The regulating compounds were purified from the ethyl acetate extract by silica gel column chromatography and HPLC. The active substance was purified and identified as rengyolone by spectroscopic methods. This compound showed inhibitory activity on caspase-3 induction, a major protease of the apoptosis cascade, with an IC50 value of 38.96 microM after 8 h of etoposide treatment in U937 cells. The expression level of caspase-3 and poly(ADP-ribose) polymerase (PARP) were dose-dependently inhibited by the compound, suggesting that rengyolone inhibits etoposide-induced apoptosis via downregulation of caspases.
    [Abstract] [Full Text] [Related] [New Search]